维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

14篇 您的检索式：作者名="Jodo S"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Elevated serum levels of soluble of Fas/APO-1 (CD95) in patients with hepatocellular carcinoma显示文摘	JODO S KOBAYSHI S NAKAJIMA Y	1998	Clin Exp Immunol1998，112，2：	1
	2	Elevated serum levels of soluble Fas/APO-1 in patients with hepatocellular carcinoma 显示文摘	Jodo S Kobayashi S Nakajima Y	1998	Clin Exp Immune1998，112，2：	1
	3	Serum levels of soluble Fas/APO-1 (CD95)and its molecular structure in patients with systemic lupus erythematosus(SLE) and other autoimmune diseases 显示文摘	Jodo S Kobayashi S Kayagaki N	1997	Clin Exp Immunol1997，107，：	1
	4	Elevated serum levels of sol- uble Fas/APO-1 ( CD95 ) in patients with hepatocellular carcinoma 显示文摘	Jodo S Kobayashi S Nakajima Y	1998	Clin Exp Immunol1998，112，2：	1
	5	显示文摘	Kobayshi S Kayagaki N	1997	Clin Exp Immunol1997，107，：	1
	6	Serum levels of soluble Fas/A po-1(CD95) and is molecular structure in patients with systemic lupus erythemat osus(SLE) and other autoimmune diseases显示文摘	Kobayashi S Kayagaki N	1997	Clin Exp Immunol1997，107，1：	1
	7	Anti-CD95-induced lethality requires radioresistant Fcgamma RII+cells A novel mechanism for fulminant hepatic failure 显示文摘	Jodo S Kung J T Xiao S	2003	J Biol Chem2003，278，9：	1
	8	A woman with infectious endocarditis caused by Abiotrophia defectiva显示文摘	Hashimoto T Jodo S Furusaki A	2004	Intern Med2004，43，10：	1
	9	Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma显示文摘	Jodo S Kobayashi S Nakajima Y	1998	Clin Exp Immunol1998，112，2：	1
	10	Tripartite relationship among P300, clinical features and brain structure in neuroleptie- naive schizophrenia显示文摘	Hoshino KY Takeuchi S Jodo E	2005	Psychiatry ClinNeurosci2005，59，4：	1
	11	Elevated serum levels of soluble Fas/APO-1(CD95) in patients with hepatocellular carcinoma显示文摘	Jodo S Kobayashi S Nakajima Y	1998	Clin Exp Immunol1998，112，1：	1
	12	Novel negative regulator of expression in Fas ligand (CD178) cytoplasmic tail: evidence for translational regulation and against Fas ligand retention in secretory lysosomes 显示文摘	Xiao S Deshmukh US Jodo S	2004	J Immunol2004，173，：	1
	13	Elevated serum levels of-soluble Fas/Apo - 1 ( CD95 ) in patients with hepatocellularcareinoma 显示文摘	Jodo S Kobayashi S Nakajima Y	1998	Clin Exp Immunol1998，112，2：	1
	14	Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma显示文摘	Jodo S Kobayashi S Nakajima Y	1998	Clin Exp Immunol1998，112，2：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费